Cambridge Investment Research Advisors, Inc. Adaptive Biotechnologies Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$25.17 - $36.85 $157,916 - $231,196	-6,274 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$30.02 - $39.87 $23,625 - $31,377	-787 Reduced 11.15%	6,274 $213,000
Q2 2021 Aug 10, 2021	BUY	$32.22 - $44.59 $227,505 - $314,849	7,061 New	7,061 $288,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$178 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$85.5 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$69.3 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$68.9 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$63.2 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account